Pharma Market Insights: Generics
Biosimilars. Biobetters. Branded and generic drugs. Specialty generics. Pay-for-delay.
Individually, they represent big questions for the pharmaceutical industry.
Together-in FirstWord's Pharma Market Insights: Generics Collection-we find the big answers. For the first... |
Smoking Cessation Aids in Australia
This Smoking Cessation Aids in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data... |
Depression - Pipeline Review
H2 2011
Depression - Pipeline Review, H2 2011
Summary
Global Markets Direct's, 'Depression - Pipeline Review, H2 2011', provides an overview of the Depression therapeutic pipeline. This report provides information on the therapeutic development... |
Emerging Generic Drug Companies Worldwide 2007
The pace of corporate consolidation grows ever faster - eight significant acquisitions were announced in 2006:
Target
Andrx, Mayne Pharma, Betapharm, Pliva, Matrix, Zentiva, Terapia, Hemofarm, Sindan ... |
Sinusitis - Pipeline Review
H2 2011
Sinusitis - Pipeline Review, H2 2011
Summary
Global Markets Direct's, 'Sinusitis - Pipeline Review, H2 2011', provides an overview of the Sinusitis therapeutic pipeline. This report provides information on the therapeutic development... |
Bulk Paclitaxel
A Global Update of Market Trends & Opportunities
World bulk paclitaxel market stands enthused by the effervescent levels of research and development. With market participants injecting resources into developing unique paclitaxel formulations, emergence of new disease indications is... |
The Pharmaceutical Market: Australia
The Pharmaceutical Market: AUSTRALIA- Review
Economically, Australia's GDP is projected to be the fifth largest in the Asia Pacific region in 2016. In terms of GDP per capita, Australia will be... |
Mayne Pharma Group Limited (formerly Halcygen Pharmaceuticals)-Therapeutic Competitors Report
Mayne Pharma Group Limited (formerly Halcygen Pharmaceuticals)-Therapeutic Competitors Report Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products... |
Generic Drugs: World Market Outlook
22011-2021
How will the market for generic drugs perform from 2011? Visiongain's report shows you potential revenues to 2021. Find opportunities and prospects there.
The world generics market has great potential to... |
The World Generic Market Report
2011
A complete global analysis of the prospects for markets and companies in this dynamic industry sector
Features and benefits of this thoroughly-researched and highly-regarded management report:
High quality: Original research, novel 5-year... |
Partnering in the Global Generics Industry 2010
A guide to companies
"Facts, statistics and insights on 168 medium-sized generic manufacturers from 40 countriesThe operating environment for generics companies is changing rapidly as the industry matures and growth focuses on new market... |
Mylan Inc. – Product Pipeline Review
H2 2011
Summary
Global Market Direct's pharmaceuticals report, 'Mylan Inc. - Product Pipeline Review - H2 2011' provides data on the Mylan Inc.'s research and development focus. The report includes information on current... |
Growth Strategies for Supergenerics Organizations
Supergenerics companies are focusing on more challenging therapy areas of supergeneric development such as obesity and rheumatoid arthritis/pain which have seen NCEs fail and drug withdrawals over the last few... |
Mayne Pharma Limited - Product Pipeline Review
Q4 2010
Mayne Pharma Limited - Product Pipeline Review - Q4 2010
Summary
Global Market Direct's pharmaceuticals report, "Mayne Pharma Limited - Product Pipeline Review - Q4 2010" provides data on the company's research... |
SuperGen, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
SuperGen, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
SuperGen, Inc. (SuperGen) is a pharmaceutical company engaged in the discovery, development and marketing of novel therapies for the treatment... |
Biosimilars
Evolution or Revolution
The pharmaceutical market's fastest growing sector, biotechnology, is about to change: biosimilars, generic biotech drugs, are coming. This comprehensive new guide gives you the information you need to operate... |
The Australia Pharmaceuticals Competitive Intelligence Report
2010
The Australia Pharmaceuticals & Healthcare Competitive Intelligence Report is an essential resource for manufacturers, investors and suppliers analysing and comparing the strategies adopted by major players as they seek to... |
Generic Pharmaceuticals Industry Report - Global
Business Performance Analysis
The Global Generic Pharmaceuticals Industry Report
This report is an in-depth financial evaluation of the Global Generic Pharmaceuticals Industry Report. Using the unique Plimsoll method of analysis, each of the top... |
The Pharmaceutical Market: India
The Pharmaceutical Market: INDIA- Review
The Indian pharmaceutical market is highly competitive and remains dominated by low priced, domestically-produced generics. Despite having the second largest population in the world and a... |
Bulk Paclitaxel
This report analyzes the worldwide markets for Bulk Paclitaxel in kilograms and US$ Million. The report provides separate comprehensive analytics for the US, and Rest of World. Annual forecasts are... |
Acne
Pipeline Assessment and Market Forecasts to 2017
GlobalData, the industry analysis specialist, has released a new report, ""Acne - Pipeline Assessment and Market Forecasts to 2017"". The report is an essential source of information and analysis on... |
Esophagitis - Pipeline Review
H2 2011
Summary
Global Markets Direct's, 'Esophagitis - Pipeline Review, H2 2011', provides an overview of the Esophagitis therapeutic pipeline. This report provides information on the therapeutic development for Esophagitis, complete with latest... |
Prospects for Pharma Mergers, Acquisitions and Alliances
2010-2020
How will M&A affect the pharma industry this decade?
Last year was important for pharmaceutical mergers and acquisitions, with total deal values in 2009 reaching almost $150bn. Driving this activity were... |
Dermatophytic Onychomycosis Therapeutics
Pipeline Assessment and Market Forecasts to 2017
Summary
GlobalData, the industry analysis specialist, has released its new report, 'Dermatophytic Onychomycosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017'. The report is an essential source of information and... |
Generics: Global Industry Guide
Generics: Global Industry Guide is an essential resource for top-level data and analysis covering the Generics industry. It includes detailed data on market size and segmentation, textual analysis of the... |
